BioSpace News Archive

Bone Staple Systems Market 2019-2023| Evolving Opportunities with Arthrex Inc. and Auxein Medical | Technavio

Technavio has been monitoring the global bone staple systems market and the market is poised to grow by USD 50.67 million during 2019-2023, progressing at a CAGR of over 7% during the forecast period.

October 7, 2019
·
4 min read
Business

Bright Health Brings Its Innovative Model to South Carolina in Collaboration with Southeastern Health Partners in 2020

Today, Bright Health announced details of its 2020 individual and family plans and Medicare Advantage plans for South Carolina

October 7, 2019
·
5 min read
Biotech Bay

Ahram Biosystems Announces Launch of the ASF Fast POCT System

Ahram Biosystems, Inc. today announced the launch of the ASF Fast POCT System for on-site diagnosis of African swine fever (ASF) that does not require cumbersome nucleic acid extraction process.

October 7, 2019
·
1 min read
Global Autoimmune Hemolytic Anemia Therapeutics Market 2019-2023 | Evolving Opportunities with Amneal Pharmaceuticals Inc. and Baxter International Inc. | Technavio

The global autoimmune hemolytic anemia therapeutics market size is poised to grow by USD 220.18 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of over 9% during the forecast period.

October 7, 2019
·
4 min read
BioCapital

New Family Research Council Map Shows Which States Have Strong Born-Alive Protections

Family Research Council today released a first-of-its-kind set of maps showing the strength of born-alive abortion survivor protection laws and the legal status of late term abortion in every state

October 7, 2019
·
3 min read
Job Trends

Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years

AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced research results showing ProChondrix® CR maintains consistent, high cell viability for two years when stored at -80̊ C.

October 7, 2019
·
2 min read
BioCapital

JFPS 2019: Sharing the vision in pharmacy

JFPS 2019 emphasizes health and readiness for U.S. military personnel

October 7, 2019
·
2 min read
ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants

The Options are exercisable on or before October 4, 2029 at the price of US$3.23 per Common share and are granted in accordance with the polices of the TSX Venture Exchange and the terms and conditions of the Existing Option Plan.

October 7, 2019
·
9 min read
Policy

Amyris Files Form 10-Qs to Achieve Compliance - Notes Receipt of Nasdaq Deficiency Notification

The company also noted that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed these quarterly reports on Form 10-Q in accordance with the required September 30 deadline

October 7, 2019
·
1 min read
Renewal of Agreement to Establish a Funding Framework and Funding Rules for the Cree Board of Health and Social Services of James Bay for the period 2019-2024

This is the third five-year agreement and funding framework for the Cree Health Board entered into with the Government of Quebec.

October 7, 2019
·
2 min read